Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from HOOKIPA Pharma

HOOKIPA Pharma's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million.

Benzinga · Jun 21, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Apr 4, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Mar 25, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

HOOKIPA Pharma's Return On Capital Employed Overview

Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter.

Benzinga · Mar 25, 2022

HOOKIPA Pharma: Q4 Earnings Insights

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings

Benzinga · Mar 24, 2022

HOOKIPA Pharma Earnings Preview

HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that HOOKIPA Pharma will report an earnings per share (EPS) of $-0.58.

Benzinga · Mar 23, 2022

How To Attend HOOKIPA Pharma Q4 2021 Earnings Conference Call

HOOKIPA Pharma (NASDAQ:HOOK) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend HOOKIPA Pharma (HOOK) Conference Call Follow this link to access the live webcast.

Benzinga · Mar 18, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

1

Coverage From

Benzinga

Organisations

WAVE Life Sciences

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

423,736 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play